We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

2020 AACC Annual Scientific Meeting & Clinical Lab Expo to Be an All Virtual Event Due to Coronavirus Pandemic

By LabMedica International staff writers
Posted on 25 Aug 2020
The American Association for Clinical Chemistry (AACC Washington, DC, USA) has decided to hold the 2020 AACC Annual Scientific Meeting & Clinical Lab Expo as a virtual event, rather than as a live meeting, due to the ongoing coronavirus pandemic.

AACC’s flagship scientific conference and expo will now be offered on an innovative digital platform built for learning, collaboration, networking, and technology exploration. The AACC has reiterated its commitment to delivering a meeting experience comparable in value and impact to its typical face-to-face conference and expo. A virtual meeting will ensure the safety of a global audience while providing greater accessibility and flexibility for the attendees to consume world-class scientific content in the way that is most convenient for them.

Illustration
Illustration

The virtual event will be held on December 13-17 and AACC’s online registration site for the virtual meeting will be available on September 15.

Related Links:
American Association for Clinical Chemistry (AACC)


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
New
Hematology Consumables
Bioblood Devices
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker

Latest Industry News

Roche to Acquire PathAI for Up to $1.05 Billion to Strengthen AI Diagnostics Portfolio
25 Aug 2020  |   Industry

FDA Clears Blood-Based Companion Diagnostic for Advanced Breast Cancer Therapy
25 Aug 2020  |   Industry

CareDx Expands Precision Oncology Portfolio with Naveris Acquisition
25 Aug 2020  |   Industry



ADLM